Tower Research Capital (TRC)’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-6,619
| Closed | -$350K | – | 5606 |
|
|
2020
Q3 | $350K | Buy |
6,619
+5,471
| +477% | +$338K | ﹤0.01% | 2048 |
|
|
2020
Q2 | $70K | Buy |
+1,148
| New | +$66.4K | ﹤0.01% | 2786 |
|
|
2020
Q1 | – | Sell |
-221
| Closed | -$13K | – | 4355 |
|
|
2019
Q4 | $13K | Sell |
221
-264
| -54% | -$14K | ﹤0.01% | 2224 |
|
|
2019
Q3 | $26K | Buy |
485
+283
| +140% | +$16.5K | ﹤0.01% | 2306 |
|
|
2019
Q2 | $12K | Sell |
202
-437
| -68% | -$27.5K | ﹤0.01% | 2478 |
|
|
2019
Q1 | $39K | Buy |
639
+581
| +1,002% | +$38.4K | ﹤0.01% | 1903 |
|
|
2018
Q4 | $4K | Sell |
58
-389
| -87% | -$23.2K | ﹤0.01% | 3113 |
|
|
2018
Q3 | $26K | Buy |
447
+401
| +872% | +$20.5K | ﹤0.01% | 2181 |
|
|
2018
Q2 | $2K | Buy |
+46
| New | +$1.98K | ﹤0.01% | 3417 |
|
|
2018
Q1 | – | Sell |
-1,640
| Closed | -$71K | – | 4115 |
|
|
2017
Q4 | $71K | Buy |
1,640
+891
| +119% | +$40K | 0.01% | 1095 |
|
|
2017
Q3 | $35K | Buy |
+749
| New | +$35.9K | ﹤0.01% | 2309 |
|
|
2017
Q2 | – | Sell |
-517
| Closed | -$28K | – | 3756 |
|
|
2017
Q1 | $28K | Buy |
517
+417
| +417% | +$22.1K | ﹤0.01% | 1084 |
|
|
2016
Q4 | $5K | Sell |
100
-165
| -62% | -$7.93K | ﹤0.01% | 3097 |
|
|
2016
Q3 | $12K | Sell |
265
-69
| -21% | -$2.77K | ﹤0.01% | 1972 |
|
|
2016
Q2 | $13K | Sell |
334
-38
| -10% | -$1.39K | ﹤0.01% | 2622 |
|
|
2016
Q1 | $13K | Sell |
372
-237
| -39% | -$8.7K | ﹤0.01% | 1726 |
|
|
2015
Q4 | $26K | Buy |
609
+96
| +19% | +$4.81K | ﹤0.01% | 1036 |
|
|
2015
Q3 | $22K | Sell |
513
-172
| -25% | -$9.28K | ﹤0.01% | 1663 |
|
|
2015
Q2 | $35K | Buy |
685
+131
| +24% | +$5.59K | ﹤0.01% | 1645 |
|
|
2015
Q1 | $22K | Buy |
554
+407
| +277% | +$16K | ﹤0.01% | 2177 |
|
|
2014
Q4 | $6K | Buy |
147
+85
| +137% | +$3.24K | ﹤0.01% | 2630 |
|
|
2014
Q3 | $2K | Sell |
62
-2,541
| -98% | -$74.6K | ﹤0.01% | 3923 |
|
|
2014
Q2 | $70K | Buy |
2,603
+2,400
| +1,182% | +$62.5K | 0.01% | 1088 |
|
|
2014
Q1 | $5K | Sell |
203
-1,574
| -89% | -$37.7K | ﹤0.01% | 3325 |
|
|
2013
Q4 | $38K | Buy |
1,777
+745
| +72% | +$15.3K | 0.01% | 1638 |
|
|
2013
Q3 | $20K | Buy |
1,032
+825
| +399% | +$14.6K | ﹤0.01% | 2696 |
|
|
2013
Q2 | $3K | Buy |
+207
| New | +$3.33K | ﹤0.01% | 3358 |
|
Other funds holding BSTC
Tower Research Capital (TRC)'s BSTC Position: Q4 2020 in Review
Tower Research Capital (TRC) sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 6,619 shares — an estimated $350K sold.
Tower Research Capital (TRC) first reported a position in BSTC in Q2 2013 and held it in 27 quarters. The position peaked at $350K in Q3 2020. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- Tower Research Capital (TRC) reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- Tower Research Capital (TRC) sold 6,619 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $350K.
- Tower Research Capital (TRC) first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 27 quarters.
- Tower Research Capital (TRC)'s BioSpecifics Technologies Corp. position peaked at $350K in Q3 2020.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.